Invention Grant
- Patent Title: Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
-
Application No.: US15869518Application Date: 2018-01-12
-
Publication No.: US10822595B2Publication Date: 2020-11-03
- Inventor: Sang Jae Kim
- Applicant: GemVax & KAEL CO., LTD. , Sang Jae KIM
- Applicant Address: KR Daejeon
- Assignee: GemVax & KAEL Co., Ltd.
- Current Assignee: GemVax & KAEL Co., Ltd.
- Current Assignee Address: KR Daejeon
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@669ea8ce com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3ab8e415 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@28225788 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@68622bfd com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7ba936e7
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C12N9/12 ; A23L33/18 ; A61K49/00 ; C07K7/08 ; A61K8/64 ; A61K8/66 ; A61Q19/00 ; G01N33/58 ; A61K47/64 ; A61K38/00
Abstract:
The present invention relates to a conjugate of cell penetrating peptide and an active ingredient; and its use. Specifically, a conjugate including a cell penetrating peptide which is a peptide comprising any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 156, a fragment of any one sequence of SEQ ID NO: 1 to SEQ ID NO: 156, or a peptide having above 80% homology with the above-mentioned sequence; and a composition comprising the same are disclosed.
Public/Granted literature
- US20180208912A1 Cell Penetrating Peptide, Conjugate Comprising Same, and Composition Comprising Conjugate Public/Granted day:2018-07-26
Information query
